Evidence-Based Practice Recommendations
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
It may be reasonable to administer intravenous glycoprotein IIb/IIIa receptor antagonist in the precatheterization laboratory setting (e.g., ambulance, emergency department) to patients with STEMI for whom primary PCI is intended.
(https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182742c84 Last Accessed: June 24, 2024)Strength of Recommendation/Level of Evidence: IB (Procedure/treatment should be performed based on data derived from a single randomized clinical trial or nonrandomized studies evaluating limited populations.)
After PCI for STEMI, aspirin should be continued indefinitely.
(https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182742c84 Last Accessed: June 24, 2024)Strength of Recommendation/Level of Evidence: IA (Procedure/treatment should be performed based on data derived from multiple randomized clinical trials or meta-analyses evaluating multiple populations.)
For patients with DVT and/or PE, the ASH guideline panel suggests using direct oral anticoagulants (DOACs) over vitamin K antagonists.
(https://ashpublications.org//bloodadvances/article/4/19/4693/463998 Last Accessed: February 17, 2026)Strength of Recommendation/Level of Evidence: Conditional recommendation based on moderate certainty in the evidence of effects
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.